Orphazyme: Detailed NPC data reported

Research Note

2019-01-30

09:02

Orphazyme today reported the detailed follow-up data from their NPC Phase II/III clinical trial, from which preliminary top-line data was reported in September 2018.

MS

Mathias Spinnars

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.